Integrated Biopharma Buy Hold or Sell Recommendation

INBPDelisted Stock  USD 0.23  0.01  4.55%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Integrated Biopharma is 'Not Rated'. Macroaxis provides Integrated Biopharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding INBP positions. The advice algorithm takes into account all of Integrated Biopharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Integrated Biopharma's buy or sell advice are summarized below:
Real Value
0.2
Hype Value
0.23
Market Value
0.23
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Integrated Biopharma given historical horizon and risk tolerance towards Integrated Biopharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Integrated Biopharma, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
In addition, we conduct extensive research on individual companies such as Integrated and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Integrated Biopharma. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Execute Integrated Biopharma Buy or Sell Advice

The Integrated recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Integrated Biopharma. Macroaxis does not own or have any residual interests in Integrated Biopharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Integrated Biopharma's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Integrated BiopharmaBuy Integrated Biopharma
Not Rated
For the selected time horizon Integrated Biopharma has a Risk Adjusted Performance of (0), Jensen Alpha of (0.06), Total Risk Alpha of (0.74) and Treynor Ratio of 0.142
We provide advice to complement the regular expert consensus on Integrated Biopharma. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Integrated Biopharma is not overpriced, please check out all Integrated Biopharma fundamentals, including its ebitda and the relationship between the debt to equity and working capital . As Integrated Biopharma appears to be a penny stock we also urge to confirm its price to earning numbers.

Integrated Biopharma Trading Alerts and Improvement Suggestions

Integrated Biopharma is not yet fully synchronised with the market data
Integrated Biopharma has some characteristics of a very speculative penny stock
Integrated Biopharma has a very high chance of going through financial distress in the upcoming years
About 69.0% of the company shares are held by company insiders

Integrated Biopharma Returns Distribution Density

The distribution of Integrated Biopharma's historical returns is an attempt to chart the uncertainty of Integrated Biopharma's future price movements. The chart of the probability distribution of Integrated Biopharma daily returns describes the distribution of returns around its average expected value. We use Integrated Biopharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Integrated Biopharma returns is essential to provide solid investment advice for Integrated Biopharma.
Mean Return
-0.11
Value At Risk
-9.09
Potential Upside
8.70
Standard Deviation
5.22
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Integrated Biopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Integrated Biopharma Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Integrated . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Integrated Biopharma Buy or Sell Advice

When is the right time to buy or sell Integrated Biopharma? Buying financial instruments such as Integrated OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Integrated Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Processed Foods Thematic Idea Now

Processed Foods
Processed Foods Theme
Companies producing and distributing processed foods to retail sectors. The Processed Foods theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Processed Foods Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Integrated Biopharma information on this page should be used as a complementary analysis to other Integrated Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Integrated OTC Stock

If you are still planning to invest in Integrated Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Integrated Biopharma's history and understand the potential risks before investing.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Global Correlations
Find global opportunities by holding instruments from different markets